Advertisement

The cognitive cost of reducing relapse to cocaine-seeking with mGlu5 allosteric modulators

  • Christina Gobin
  • Marek SchwendtEmail author
Original Investigation
  • 93 Downloads

Abstract

Rationale

Cocaine use disorder (CUD) remains difficult to treat with no FDA-approved medications to reduce relapse. Antagonism of metabotropic glutamate receptor 5 (mGlu5) has been demonstrated to decrease cocaine-seeking but may also further compromise cognitive function in long-term cocaine users.

Objectives

Here we assessed the effect of repeated administration of negative or positive allosteric modulators (NAM or PAM) of mGlu5 on both cognitive performance and (context+cue)-primed cocaine-seeking after prolonged abstinence (≥ 45 days).

Methods

Adult male Sprague-Dawley rats underwent 6 days of short-access (1 h/day) and 12 days of long-access (6 h/day) cocaine self-administration. Rats were then trained and tested in a delayed match-to-sample (DMS) task to establish baseline working memory performance over a 5-day block of testing. Next, rats received daily systemic administration of the mGlu5 NAM 3-((2-methyl-1,3-thiazol-4-yl)ethynyl)pyridine hydrochloride (MTEP; 3 mg/kg), the mGlu5 PAM 3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide (CDPPB; 30 mg/kg) or vehicle prior to DMS testing during a block of 5 days, followed by a 5-day washout DMS testing block.

Results

MTEP and CDPPB decreased drug-seeking in response to cocaine-associated cues after prolonged abstinence. However, repeated treatment with MTEP impaired working memory, while CDPPB had no effects on performance.

Conclusions

These results emphasize the relevance of evaluating cognitive function within the context of investigating pharmacotherapies to treat CUD. Further research is needed to determine how two mechanistically different pharmacological compounds can exert the same behavioral effects to reduce cocaine-seeking.

Keywords

Addiction Self-administration Cocaine Relapse Working memory mGlu5 receptor 

Notes

Acknowledgments

The authors thank Dr. Jennifer Bizon and Dr. Joseph McQuail for their input on the design of the DMS task and Dr. Lori Knackstedt for her valuable comments during manuscript preparation. We also thank Mr. Spencer Berman, Mr. Kyle Fontaine, Ms. Carly Wallace, and Ms. Vera Monlux for their assistance with conducting behavioral studies.

Funding information

This research was supported by the University of Florida McKnight Brain Institute pilot award (MS).

Compliance with ethical standards

All experimental protocols were approved by the University of Florida Institutional Animal Care and Use Committee and consistent with guidelines of the NIH Guide for the Care and Use of Laboratory Animals.

Conflict of interest

The authors declare that they have no conflicts of interest.

Supplementary material

213_2019_5351_Fig5_ESM.png (41 kb)
ESM Fig.5

(PNG 40.7 kb)

213_2019_5351_MOESM1_ESM.eps (2 mb)
ESM 1 (EPS 2.04 mb)
213_2019_5351_Fig6_ESM.png (69 kb)
ESM Fig.6

(PNG 69.3 kb)

213_2019_5351_MOESM2_ESM.eps (2.1 mb)
ESM 2 (EPS 2.08 mb)

References

  1. Aharonovich E, Hasin DS, Brooks AC, Liu X, Bisaga A, Nunes EV (2006) Cognitive deficits predict low treatment retention in cocaine dependent patients. Drug Alcohol Depend 81:313–322.  https://doi.org/10.1016/j.drugalcdep.2005.08.003 CrossRefPubMedGoogle Scholar
  2. Akhlaghpour H, Wiskerke J, Choi JY, Taliaferro JP, Au J, Witten IB (2016) Dissociated sequential activity and stimulus encoding in the dorsomedial striatum during spatial working memory. Elife 5:5.  https://doi.org/10.7554/eLife.19507 CrossRefGoogle Scholar
  3. Albein-Urios N, Martinez-González JM, Óscar L et al (2012) Comparison of impulsivity and working memory in cocaine addiction and pathological gambling: implications for cocaine-induced neurotoxicity. Drug Alcohol Depend 126:1–6.  https://doi.org/10.1016/j.drugalcdep.2012.03.008 CrossRefPubMedGoogle Scholar
  4. Anderson JJ, Bradbury MJ, Giracello DR, Chapman DF, Holtz G, Roppe J, King C, Cosford ND, Varney MA (2003) In vivo receptor occupancy of mGlu5 receptor antagonists using the novel radioligand [3H]3-methoxy-5-(pyridin-2-ylethynyl)pyridine). Eur J Pharmacol 473:35–40.  https://doi.org/10.1016/s0014-2999(03)01935-6
  5. Beas BS, Setlow B, Bizon JL (2013) Distinct manifestations of executive dysfunction in aged rats. Neurobiol Aging 34:2164–2174.  https://doi.org/10.1016/j.neurobiolaging.2013.03.019 CrossRefPubMedPubMedCentralGoogle Scholar
  6. Benneyworth MA, Hearing MC, Asp AJ, Madayag A, Ingebretson AE, Schmidt CE, Silvis KA, Larson EB, Ebner SR, Thomas MJ (2019) Synaptic depotentiation and mGluR5 activity in the nucleus accumbens drive cocaine-primed reinstatement of place preference. J Neurosci 39:4785–4796.  https://doi.org/10.1523/JNEUROSCI.3020-17.2019 CrossRefPubMedGoogle Scholar
  7. Ben-Shahar OM, Szumlinski KK, Lominac KD, Cohen A, Gordon E, Ploense KL, DeMartini J, Bernstein N, Rudy NM, Nabhan AN, Sacramento A, Pagano K, Carosso GA, Woodward N (2012) Extended access to cocaine self-administration results in reduced glutamate function within the medial prefrontal cortex. Addict Biol. 17:746–757.  https://doi.org/10.1111/j.1369-1600.2011.00428.x.
  8. Ben-Shahar O, Sacramento AD, Miller BW, Webb SM, Wroten MG, Silva HE, Caruana AL, Gordon EJ, Ploense KL, Ditzhazy J, Kippin TE, Szumlinski KK (2013) Deficits in ventromedial prefrontal cortex group 1 metabotropic glutamate receptor function mediate resistance to extinction during protracted withdrawal from an extensive history of cocaine self-administration. J Neurosci 33:495–506.  https://doi.org/10.1523/JNEUROSCI.3710-12.2013 CrossRefPubMedPubMedCentralGoogle Scholar
  9. Brady KT, Gray KM, Tolliver BK, Tolliver BK (2011) Cognitive enhancers in the treatment of substance use disorders: clinical evidence. Pharmacol Biochem Behav 99:285–294.  https://doi.org/10.1016/j.pbb.2011.04.017 CrossRefPubMedPubMedCentralGoogle Scholar
  10. Carelli RM, Williams JG, Hollander JA (2003) Basolateral amygdala neurons encode cocaine self-administration and cocaine-associated cues. J Neurosci 23:8204–8211.  https://doi.org/10.1523/JNEUROSCI.23-23-08204.2003 CrossRefPubMedPubMedCentralGoogle Scholar
  11. Chiamulera C, Epping-Jordan MP, Zocchi A, Marcon C, Cottiny C, Tacconi S, Corsi M, Orzi F, Conquet F (2001) Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice. Nat Neurosci 4:873–874.  https://doi.org/10.1038/nn0901-873 CrossRefPubMedGoogle Scholar
  12. Cleva RM, Hicks MP, Gass JT, Wischerath KC, Plasters ET, Widholm JJ, Olive MF (2011) mGluR5 positive allosteric modulation enhances extinction learning following cocaine self-administration. Behav Neurosci 125:10–19.  https://doi.org/10.1037/a0022339 CrossRefPubMedPubMedCentralGoogle Scholar
  13. Cunha PJ, Gonçalves PD, Ometto M, dos Santos B, Nicastri S, Busatto GF, de Andrade AG (2013) Executive cognitive dysfunction and ADHD in cocaine dependence: searching for a common cognitive endophenotype for addictive disorders. Front Psychiatry 4:126.  https://doi.org/10.3389/fpsyt.2013.00126 CrossRefPubMedPubMedCentralGoogle Scholar
  14. Dackis CA, Kampman KM, Lynch KG, Pettinati HM, O’Brien CP (2005) A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology 30:205–211.  https://doi.org/10.1038/sj.npp.1300600 CrossRefPubMedGoogle Scholar
  15. Fowler SW, Walker JM, Klakotskaia D, Will MJ, Serfozo P, Simonyi A, Schachtman TR (2013) Effects of a metabotropic glutamate receptor 5 positive allosteric modulator, CDPPB, on spatial learning task performance in rodents. Neurobiol Learn Mem 99:25–31.  https://doi.org/10.1016/j.nlm.2012.10.010 CrossRefPubMedGoogle Scholar
  16. Freeman WM, Patel KM, Brucklacher RM, Lull ME, Erwin M, Morgan D, Roberts DCS, Vrana KE (2008) Persistent alterations in mesolimbic gene expression with abstinence from cocaine self-administration. Neuropsychopharmacology 33:1807–1817.  https://doi.org/10.1038/sj.npp.1301577 CrossRefPubMedGoogle Scholar
  17. Gass JT, Olive MF (2009) Positive allosteric modulation of mGluR5 receptors facilitates extinction of a cocaine contextual memory. Biol Psychiatry 65:717–720.  https://doi.org/10.1016/j.biopsych.2008.11.001 CrossRefPubMedGoogle Scholar
  18. Gass JT, Osborne MPH, Watson NL, Brown JL, Olive MF (2009) mGluR5 antagonism attenuates methamphetamine reinforcement and prevents reinstatement of methamphetamine-seeking behavior in rats. Neuropsychopharmacology 34:820–833.  https://doi.org/10.1038/npp.2008.140 CrossRefPubMedGoogle Scholar
  19. Gawin FH, Kleber HD (1986) Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Clinical observations. Arch Gen Psychiatry 43:107–113CrossRefPubMedGoogle Scholar
  20. Gobin C, Schwendt M (2017) The effects of extended-access cocaine self-administration on working memory performance, reversal learning and incubation of cocaine-seeking in adult male rats. J Addict Prev 5:1–6.  https://doi.org/10.13188/2330-2178.1000035 CrossRefGoogle Scholar
  21. Gobin C, Shallcross J, Schwendt M (2019) Neurobiological substrates of persistent working memory deficits and cocaine-seeking in the prelimbic cortex of rats with a history of extended access to cocaine self-administration. Neurobiol Learn Mem 161:92–105.  https://doi.org/10.1016/J.NLM.2019.03.007 CrossRefPubMedGoogle Scholar
  22. Goldstein RZ, Leskovjan AC, Hoff AL, Hitzemann R, Bashan F, Khalsa SS, Wang GJ, Fowler JS, Volkow ND (2004) Severity of neuropsychological impairment in cocaine and alcohol addiction: association with metabolism in the prefrontal cortex. Neuropsychologia 42:1447–1458.  https://doi.org/10.1016/J.NEUROPSYCHOLOGIA.2004.04.002 CrossRefPubMedGoogle Scholar
  23. Grimm JW, Hope BT, Wise RA, Shaham Y (2001) Neuroadaptation. Incubation of cocaine craving after withdrawal. Nature 412:141–142.  https://doi.org/10.1038/35084134 CrossRefPubMedPubMedCentralGoogle Scholar
  24. Hao Y, Martin-Fardon R, Weiss F (2010) Behavioral and functional evidence of metabotropic glutamate receptor 2/3 and metabotropic glutamate receptor 5 dysregulation in cocaine-escalated rats: factor in the transition to dependence. Biol Psychiatry 68:240–248.  https://doi.org/10.1016/j.biopsych.2010.02.011 CrossRefPubMedPubMedCentralGoogle Scholar
  25. Hernandez CM, McQuail JA, Schwabe MR, et al (2018) Age-related declines in prefrontal cortical expression of metabotropic glutamate receptors that support working memory. eneuro 5:ENEURO.0164-18.2018. doi:  https://doi.org/10.1523/ENEURO.0164-18.2018
  26. Jovanovski D, Erb S, Zakzanis KK (2005) Neurocognitive deficits in cocaine users: a quantitative review of the evidence. J Clin Exp Neuropsychol 27:189–204.  https://doi.org/10.1080/13803390490515694 CrossRefPubMedGoogle Scholar
  27. Keck TM, Yang H-J, Bi G-H, Huang Y, Zhang HY, Srivastava R, Gardner EL, Newman AH, Xi ZX (2013) Fenobam sulfate inhibits cocaine-taking and cocaine-seeking behavior in rats: implications for addiction treatment in humans. Psychopharmacology 229:253–265.  https://doi.org/10.1007/s00213-013-3106-9 CrossRefPubMedPubMedCentralGoogle Scholar
  28. Keck TM, Zou M-F, Bi G-H, Zhang HY, Wang XF, Yang HJ, Srivastava R, Gardner EL, Xi ZX, Newman AH (2014) A novel mGluR5 antagonist, MFZ 10-7, inhibits cocaine-taking and cocaine-seeking behavior in rats. Addict Biol 19:195–209.  https://doi.org/10.1111/adb.12086 CrossRefPubMedGoogle Scholar
  29. Kenny PJ, Boutrel B, Gasparini F, Koob GF, Markou A (2005) Metabotropic glutamate 5 receptor blockade may attenuate cocaine self-administration by decreasing brain reward function in rats. Psychopharmacology 179:247–254.  https://doi.org/10.1007/s00213-004-2069-2 CrossRefPubMedGoogle Scholar
  30. Kim J, Perry C, Luikinga S et al (2014) Extinction of a cocaine-taking context that protects against drug-primed reinstatement is dependent on the metabotropic glutamate 5 receptor. Addict Biol 20:482–489.  https://doi.org/10.1111/adb.12142 CrossRefPubMedGoogle Scholar
  31. Knackstedt L, Kalivas P (2009) Glutamate and reinstatement. Curr Opin Pharmacol 9:59–64.  https://doi.org/10.1016/J.COPH.2008.12.003 CrossRefPubMedPubMedCentralGoogle Scholar
  32. Knackstedt L, Schwendt M (2016) mGlu5 receptors and relapse to cocaine-seeking: the role of receptor trafficking in postrelapse extinction learning deficits. Neural Plast 2016:9312508–9312510.  https://doi.org/10.1155/2016/9312508 CrossRefPubMedPubMedCentralGoogle Scholar
  33. Knackstedt LA, Trantham-Davidson HL, Schwendt M (2014) The role of ventral and dorsal striatum mGluR5 in relapse to cocaine-seeking and extinction learning. Addict Biol 19:87–101.  https://doi.org/10.1111/adb.12061 CrossRefPubMedGoogle Scholar
  34. Koob GF, Volkow ND (2016) Neurobiology of addiction: a neurocircuitry analysis. Lancet Psychiatry 3:760–773.  https://doi.org/10.1016/S2215-0366(16)00104-8 CrossRefPubMedPubMedCentralGoogle Scholar
  35. Kübler A, Murphy K, Garavan H (2005) Cocaine dependence and attention switching within and between verbal and visuospatial working memory. Eur J Neurosci 21:1984–1992.  https://doi.org/10.1111/j.1460-9568.2005.04027.x CrossRefPubMedGoogle Scholar
  36. Kumaresan V, Yuan M, Yee J, Famous KR, Anderson SM, Schmidt HD, Pierce RC (2009) Metabotropic glutamate receptor 5 (mGluR5) antagonists attenuate cocaine priming- and cue-induced reinstatement of cocaine seeking. Behav Brain Res 202:238–244.  https://doi.org/10.1016/j.bbr.2009.03.039 CrossRefPubMedPubMedCentralGoogle Scholar
  37. LaCrosse AL, Burrows BT, Angulo RM et al (2014) mGluR5 positive allosteric modulation and its effects on MK-801 induced set-shifting impairments in a rat operant delayed matching/non-matching-to-sample task. Psychopharmacology 232:251–258.  https://doi.org/10.1007/s00213-014-3653-8 CrossRefPubMedPubMedCentralGoogle Scholar
  38. Lee B, Platt DM, Rowlett JK, Adewale AS, Spealman RD (2005) Attenuation of behavioral effects of cocaine by the metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)-pyridine in squirrel monkeys: comparison with dizocilpine. J Pharmacol Exp Ther 312:1232–1240.  https://doi.org/10.1124/jpet.104.078733 CrossRefPubMedGoogle Scholar
  39. Li X, Peng X-Q, Jordan CJ, Li J, Bi GH, He Y, Yang HJ, Zhang HY, Gardner EL, Xi ZX (2018) mGluR5 antagonism inhibits cocaine reinforcement and relapse by elevation of extracellular glutamate in the nucleus accumbens via a CB1 receptor mechanism. Sci Rep 8:3686.  https://doi.org/10.1038/s41598-018-22087-1 CrossRefPubMedPubMedCentralGoogle Scholar
  40. Lu L, Grimm JW, Shaham Y, Hope BT (2003) Molecular neuroadaptations in the accumbens and ventral tegmental area during the first 90 days of forced abstinence from cocaine self-administration in rats. J Neurochem 85:1604–1613CrossRefPubMedGoogle Scholar
  41. Mahoney JJ (2018) Cognitive dysfunction in individuals with cocaine use disorder: potential moderating factors and pharmacological treatments. Exp Clin Psychopharmacol 27:203–214.  https://doi.org/10.1037/pha0000245 CrossRefPubMedGoogle Scholar
  42. Marszalek-Grabska M, Gibula-Bruzda E, Bodzon-Kulakowska A, Suder P, Gawel K, Talarek S, Listos J, Kedzierska E, Danysz W, Kotlinska JH (2018) ADX-47273, a mGlu5 receptor positive allosteric modulator, attenuates deficits in cognitive flexibility induced by withdrawal from “binge-like” ethanol exposure in rats. Behav Brain Res 338:9–16.  https://doi.org/10.1016/J.BBR.2017.10.007 CrossRefPubMedGoogle Scholar
  43. Martin-Fardon, Baptista, Dayas, Weiss (2009) Dissociation of the effects of MTEP [3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]piperidine] on conditioned reinstatement and reinforcement: comparison between cocaine and a conventional reinforcer. J Pharmacol Exp Ther 329:1084–1090.  https://doi.org/10.1124/jpet.109.151357 CrossRefPubMedPubMedCentralGoogle Scholar
  44. Martin-Fardon R, Weiss F (2012) (-)-2-oxa-4-aminobicylco[3.1.0]hexane-4,6-dicarboxylic acid (LY379268) and 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]piperidine (MTEP) similarly attenuate stress-induced reinstatement of cocaine seeking. Addict Biol 17:557–564.  https://doi.org/10.1111/j.1369-1600.2011.00345.x CrossRefPubMedGoogle Scholar
  45. Matzeu A, Weiss F, Martin-Fardon R (2015) Transient inactivation of the posterior paraventricular nucleus of the thalamus blocks cocaine-seeking behavior. Neurosci Lett 608:34–39.  https://doi.org/10.1016/j.neulet.2015.10.016 CrossRefPubMedPubMedCentralGoogle Scholar
  46. McFarland K, Lapish CC, Kalivas PW (2003) Prefrontal glutamate release into the core of the nucleus accumbens mediates cocaine-induced reinstatement of drug-seeking behavior. J Neurosci 23:3531–3537.  https://doi.org/10.1523/JNEUROSCI.23-08-03531.2003 CrossRefPubMedPubMedCentralGoogle Scholar
  47. Morgan PT, Angarita GA, Canavan S, Pittman B, Oberleitner L, Malison RT, Mohsenin V, Hodges S, Easton C, McKee S, Bessette A, Forselius E (2016) Modafinil and sleep architecture in an inpatient–outpatient treatment study of cocaine dependence. Drug Alcohol Depend 160:49–56.  https://doi.org/10.1016/J.DRUGALCDEP.2015.12.004 CrossRefPubMedPubMedCentralGoogle Scholar
  48. Nuijten M, Blanken P, van den Brink W, Hendriks V (2015) Modafinil in the treatment of crack-cocaine dependence in the Netherlands: results of an open-label randomised controlled feasibility trial. J Psychopharmacol 29:678–687.  https://doi.org/10.1177/0269881115582151 CrossRefPubMedGoogle Scholar
  49. Olive MF (2009) Metabotropic glutamate receptor ligands as potential therapeutics for addiction. Curr Drug Abuse Rev 2:83–98.  https://doi.org/10.2174/1874473710902010083
  50. Olive MF (2010) Cognitive effects of group I metabotropic glutamate receptor ligands in the context of drug addiction. Eur J Pharmacol 639:47–58.  https://doi.org/10.1016/j.ejphar.2010.01.029 CrossRefPubMedPubMedCentralGoogle Scholar
  51. Pace-Schott EF, Morgan PT, Malison RT, Hart CL, Edgar C, Walker M, Stickgold R (2008) Cocaine users differ from normals on cognitive tasks which show poorer performance during drug abstinence. Am J Drug Alcohol Abuse 34:109–121.  https://doi.org/10.1080/00952990701764821 CrossRefPubMedGoogle Scholar
  52. Parvaz MA, Moeller SJ, Goldstein RZ (2016) Incubation of cue-induced craving in adults addicted to cocaine measured by electroencephalography. JAMA Psychiatry 73:1127–1134.  https://doi.org/10.1001/jamapsychiatry.2016.2181 CrossRefPubMedPubMedCentralGoogle Scholar
  53. Pelloux Y, Minier-Toribio A, Hoots JK et al (2018) Opposite effects of basolateral amygdala inactivation on context-induced relapse to cocaine seeking after extinction versus punishment. J Neurosci 38:51–59.  https://doi.org/10.1523/JNEUROSCI.2521-17.2017 CrossRefPubMedPubMedCentralGoogle Scholar
  54. Perry CJ, Reed F, Zbukvic IC, Kim JH, Lawrence AJ (2016) The metabotropic glutamate 5 receptor is necessary for extinction of cocaine-associated cues. Br J Pharmacol 173:1085–1094.  https://doi.org/10.1111/bph.13437 CrossRefPubMedPubMedCentralGoogle Scholar
  55. Potvin S, Stavro K, Rizkallah É, Pelletier J (2014) Cocaine and cognition. J Addict Med 8:368–376.  https://doi.org/10.1097/ADM.0000000000000066 CrossRefPubMedGoogle Scholar
  56. Reichel CM, Schwendt M, McGinty JF et al (2011) Loss of object recognition memory produced by extended access to methamphetamine self-administration is reversed by positive allosteric modulation of metabotropic glutamate receptor 5. Neuropsychopharmacology 36:782–792.  https://doi.org/10.1038/npp.2010.212 CrossRefPubMedGoogle Scholar
  57. Rodrigues SM, Bauer EP, Farb CR, Schafe GE, LeDoux JE (2002) The group I metabotropic glutamate receptor mGluR5 is required for fear memory formation and long-term potentiation in the lateral amygdala. J Neurosci 22:5219–5229.  https://doi.org/10.1523/JNEUROSCI.22-12-05219.2002 CrossRefPubMedPubMedCentralGoogle Scholar
  58. Rogers JL, See RE (2007) Selective inactivation of the ventral hippocampus attenuates cue-induced and cocaine-primed reinstatement of drug-seeking in rats. Neurobiol Learn Mem 87:688–692.  https://doi.org/10.1016/j.nlm.2007.01.003 CrossRefPubMedPubMedCentralGoogle Scholar
  59. Romano C, Sesma MA, McDonald CT et al (1995) Distribution of metabotropic glutamate receptor mGluR5 immunoreactivity in rat brain. J Comp Neurol 355:455–469.  https://doi.org/10.1002/cne.903550310 CrossRefPubMedGoogle Scholar
  60. Scofield MD, Heinsbroek JA, Gipson CD, Kupchik YM, Spencer S, Smith ACW, Roberts-Wolfe D, Kalivas PW (2016) The nucleus accumbens: mechanisms of addiction across drug classes reflect the importance of glutamate homeostasis. Pharmacol Rev 68:816–871.  https://doi.org/10.1124/pr.116.012484 CrossRefPubMedPubMedCentralGoogle Scholar
  61. Shigemoto R, Nomura S, Ohishi H, Sugihara H, Nakanishi S, Mizuno N (1993) Immunohistochemical localization of a metabotropic glutamate receptor, mGluR5, in the rat brain. Neurosci Lett 163:53–57.  https://doi.org/10.1016/0304-3940(93)90227-C CrossRefPubMedGoogle Scholar
  62. Simonyi A, Schachtman TR, Christoffersen GRJ (2005) The role of metabotropic glutamate receptor 5 in learning and memory processes. Drug News Perspect 18:353–361.  https://doi.org/10.1358/dnp.2005.18.6.927927 CrossRefPubMedGoogle Scholar
  63. Sloan HL, Good M, Dunnett SB (2006) Double dissociation between hippocampal and prefrontal lesions on an operant delayed matching task and a water maze reference memory task. Behav Brain Res 171:116–126.  https://doi.org/10.1016/j.bbr.2006.03.030 CrossRefPubMedGoogle Scholar
  64. Stansley BJ, Conn PJ (2019) Neuropharmacological insight from allosteric modulation of mGlu receptors. Trends Pharmacol Sci 40:240–252.  https://doi.org/10.1016/J.TIPS.2019.02.006 CrossRefPubMedGoogle Scholar
  65. Stefani MR, Moghaddam B (2010) Activation of type 5 metabotropic glutamate receptors attenuates deficits in cognitive flexibility induced by NMDA receptor blockade. Eur J Pharmacol 639:26–32.  https://doi.org/10.1016/j.ejphar.2010.01.028 CrossRefPubMedPubMedCentralGoogle Scholar
  66. Streeter CC, Terhune DB, Whitfield TH, Gruber S, Sarid-Segal O, Silveri MM, Tzilos G, Afshar M, Rouse ED, Tian H, Renshaw PF, Ciraulo DA, Yurgelun-Todd DA (2008) Performance on the Stroop predicts treatment compliance in cocaine-dependent individuals. Neuropsychopharmacology 33:827–836.  https://doi.org/10.1038/sj.npp.1301465 CrossRefPubMedGoogle Scholar
  67. Timmer KM, Steketee JD (2012) Examination of a role for metabotropic glutamate receptor 5 in the medial prefrontal cortex in cocaine sensitization in rats. Psychopharmacology 221:91–100.  https://doi.org/10.1007/s00213-011-2548-1 CrossRefPubMedGoogle Scholar
  68. Uslaner JM, Parmentier-Batteur S, Flick RB, Surles NO, Lam JSH, McNaughton CH, Jacobson MA, Hutson PH (2009) Dose-dependent effect of CDPPB, the mGluR5 positive allosteric modulator, on recognition memory is associated with GluR1 and CREB phosphorylation in the prefrontal cortex and hippocampus. Neuropharmacology 57:531–538.  https://doi.org/10.1016/j.neuropharm.2009.07.022 CrossRefPubMedGoogle Scholar
  69. Uys J, LaLumiere R (2008) Glutamate: the new frontier in pharmacotherapy for cocaine addiction. CNS Neurol Disord Drug Targets 7:482–491.  https://doi.org/10.2174/187152708786927868 CrossRefPubMedGoogle Scholar
  70. Verdejo-Garcia A, Albein-Urios N, Martinez-Gonzalez JM, Civit E, de la Torre R, Lozano O (2014) Decision-making impairment predicts 3-month hair-indexed cocaine relapse. Psychopharmacology 231:4179–4187.  https://doi.org/10.1007/s00213-014-3563-9 CrossRefPubMedGoogle Scholar
  71. Vonmoos M, Hulka LM, Preller KH, Jenni D, Baumgartner MR, Stohler R, Bolla KI, Quednow BB (2013) Cognitive dysfunctions in recreational and dependent cocaine users: role of attention-deficit hyperactivity disorder, craving and early age at onset. Br J Psychiatry 203:35–43.  https://doi.org/10.1192/bjp.bp.112.118091 CrossRefPubMedGoogle Scholar
  72. Vonmoos M, Hulka LM, Preller KH, Minder F, Baumgartner MR, Quednow BB (2014) Cognitive impairment in cocaine users is drug-induced but partially reversible: evidence from a longitudinal study. Neuropsychopharmacology 39:2200–2210.  https://doi.org/10.1038/npp.2014.71 CrossRefPubMedPubMedCentralGoogle Scholar
  73. Wang, Moussawi, Knackstedt et al (2013) Role of mGluR5 neurotransmission in reinstated cocaine-seeking. Addict Biol 18:40–49.  https://doi.org/10.1111/j.1369-1600.2011.00432.x CrossRefPubMedGoogle Scholar
  74. Wei J, Carroll RJ, Harden KK, Wu G (2012) Comparisons of treatment means when factors do not interact in two-factorial studies. Amino Acids 42:2031–2035.  https://doi.org/10.1007/s00726-011-0924-0 CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Psychology DepartmentUniversity of FloridaGainesvilleUSA
  2. 2.Center for Addiction Research and Education (CARE)University of FloridaGainesvilleUSA

Personalised recommendations